Nu Skin Enterprises Inc (NUS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nu Skin Enterprises Inc (NUS) has a cash flow conversion efficiency ratio of 0.020x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($10.62 Million) by net assets ($542.74 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Nu Skin Enterprises Inc (NUS) total market value for the company's overall valuation and market capitalisation.
Nu Skin Enterprises Inc - Cash Flow Conversion Efficiency Trend (1995–2025)
This chart illustrates how Nu Skin Enterprises Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Nu Skin Enterprises Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nu Skin Enterprises Inc ranked by their cash flow conversion efficiency. Explore Nu Skin Enterprises Inc (NUS) cash flow quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Otovo AS
OL:OTOVO
|
-0.387x |
|
Adimmune Corp
TW:4142
|
-0.073x |
|
Metals Acquisition Corp. II
NYSE:MTAL
|
-0.001x |
|
Ernst Russ AG
XETRA:HXCK
|
0.066x |
|
Groupe Pizzorno Environnement SA
PA:GPE
|
0.332x |
|
Artius II Acquisition Inc.
NASDAQ:AACB
|
-0.003x |
|
Virginia National Bankshares Corp
NASDAQ:VABK
|
0.035x |
|
Hunan Copote Science Technology Co Ltd
SHG:600476
|
-0.072x |
Annual Cash Flow Conversion Efficiency for Nu Skin Enterprises Inc (1995–2025)
The table below shows the annual cash flow conversion efficiency of Nu Skin Enterprises Inc from 1995 to 2025. View today's stock price for Nu Skin Enterprises Inc for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $805.24 Million | $80.29 Million | 0.100x | -41.87% |
| 2024-12-31 | $651.46 Million | $111.74 Million | 0.172x | +18.84% |
| 2023-12-31 | $821.97 Million | $118.64 Million | 0.144x | +19.85% |
| 2022-12-31 | $897.30 Million | $108.06 Million | 0.120x | -22.36% |
| 2021-12-31 | $912.77 Million | $141.58 Million | 0.155x | -63.41% |
| 2020-12-31 | $894.27 Million | $379.14 Million | 0.424x | +108.56% |
| 2019-12-31 | $875.29 Million | $177.93 Million | 0.203x | -21.60% |
| 2018-12-31 | $781.87 Million | $202.74 Million | 0.259x | -39.61% |
| 2017-12-31 | $704.60 Million | $302.56 Million | 0.429x | +3.59% |
| 2016-12-31 | $664.07 Million | $275.26 Million | 0.415x | +6.25% |
| 2015-12-31 | $825.62 Million | $322.11 Million | 0.390x | +751.18% |
| 2014-12-31 | $942.44 Million | $-56.46 Million | -0.060x | -109.70% |
| 2013-12-31 | $858.62 Million | $530.18 Million | 0.617x | +17.27% |
| 2012-12-31 | $590.61 Million | $310.98 Million | 0.527x | +34.79% |
| 2011-12-31 | $574.24 Million | $224.31 Million | 0.391x | -2.02% |
| 2010-12-31 | $471.25 Million | $187.88 Million | 0.399x | +11.83% |
| 2009-12-31 | $375.69 Million | $133.94 Million | 0.357x | +9.12% |
| 2008-12-31 | $316.18 Million | $103.31 Million | 0.327x | +84.69% |
| 2007-12-31 | $275.01 Million | $48.65 Million | 0.177x | -25.55% |
| 2006-12-31 | $318.98 Million | $75.80 Million | 0.238x | -26.15% |
| 2005-12-31 | $354.63 Million | $114.10 Million | 0.322x | -26.88% |
| 2004-12-31 | $296.23 Million | $130.35 Million | 0.440x | +17.14% |
| 2003-12-31 | $290.25 Million | $109.03 Million | 0.376x | +30.65% |
| 2002-12-31 | $386.49 Million | $111.12 Million | 0.288x | +46.77% |
| 2001-12-31 | $379.89 Million | $74.42 Million | 0.196x | +65.57% |
| 2000-12-31 | $366.73 Million | $43.39 Million | 0.118x | +20.81% |
| 1999-12-31 | $309.40 Million | $30.30 Million | 0.098x | -78.98% |
| 1998-12-31 | $254.60 Million | $118.60 Million | 0.466x | -10.80% |
| 1997-12-31 | $177.50 Million | $92.70 Million | 0.522x | -53.55% |
| 1996-12-31 | $107.80 Million | $121.20 Million | 1.124x | +6.90% |
| 1995-12-31 | $61.80 Million | $65.00 Million | 1.052x | -- |
About Nu Skin Enterprises Inc
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and… Read more